COVID-19 among fit patients with CLL treated with venetoclax-based combinations
With more than 5 million proven infections and more than 300,000 associated deaths worldwide [1], the SARS-CoV-2 pandemic poses unprecedented challenges to health-care professionals and especially those treating and caring for patients with malignant hematological diseases. These patients often have...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12895
- Acceso en línea:
- https://www.nature.com/articles/s41375-020-0941-7
http://hdl.handle.net/20.500.12010/12895
https://doi.org/10.1038/s41375-020-0941-7
- Palabra clave:
- venetoclax
leukemia
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido